Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment
Manel Albertí-Valls, Sara Olave, Anna Olomí, Anna Macià, Núria Eritja · 2024
Read Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment by Manel Albertí-Valls, Sara Olave, Anna Olomí, Anna Macià, Núria Eritja (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11640124.txt.
Description
Manel Albertí-Valls and co-authors review how immune therapy is changing care for cancer of the womb lining. Early cases of this cancer are often cured, but cases that spread or return are hard to treat. Their 2024 review centers on drugs that free the immune system to attack tumors. It asks which patients gain most from these drugs.
A key trait is whether the tumor can fix faults in its own DNA code. Tumors that lack this repair tend to carry more faults and answer better to the drugs. Yet some such tumors stay cold, with few immune cells inside, and resist care. A few repair-fit tumors run hot and do respond. The review also covers cell-based cures now in trials for hard cases.
Catalog record
| CREATOR | Manel Albertí-Valls, Sara Olave, Anna Olomí, Anna Macià, Núria Eritja |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |